SAN FRANCISCO, CA - Oct 28, 2016 - We recently participated in the inaugural
Powering Precision Health Summit
as a platinum sponsor. Following the success and excitement of that event, we thought this was a great time to take the show on the road! Join us to hear how the ability to measure biomarkers at the earliest stages of disease progression and treatment monitoring is leading to new understanding of the biology of health and disease.
We will have a set of stimulating presentations in the areas of Oncology, Neurology and Cardiology by Quanterix user's and helpful workshops led by some of the key scientists on our Quanterix team.
Date:
November 3, 2016
Time:
9:00am-4:00pm
Location:
San Francisco, CA at the Hilton Garden Inn San Francisco Airport North
Register Here
:
http://go.quanterix.com/l/228272/2016-10-11/fd7
Agenda:
8:00-9:00am: Registration
9:00-9:10am: Opening remarks from Mark Roskey, Quanterix
9:10-9:50am: Ultra-sensitive detection of interferon alpha protein by Simoa, new insights into disease pathogenesis with Jeremie Decalf, Genentech
9:50-10:30am: Probing the depths of the peripheral immune system: ultra sensitive quantification of cytokines for immuno-oncology and autoimmune disease research with Dominic Eisinger, Myriad RBM
10:30-10:45am: Coffee Break
10:45-11:20: Evaluation of Trace Levels of Asthma-Relevant Cytokines in Serum Using the High Sensitivity Quanterix Simoa HD-1 Platform with Monica Gavala, Amgen
11:20-12:00pm: Simoa Application and literature review with Divya Rao, Quanterix
12:00-1:00pm: Lunch
1:00-4:00pm: Simoa HD-1 Users Workshop, led by Purvish Patel, Sharel Figueredo and Divya Rao, Quanterix
- Latest updates and best practices for optimal HD-1 Performance
- Assay validation process for Quanterix Assays
- Homebrew- new streamlined protocols and tools; helper beads
- Multiplex Simoa Assays- practical considerations
- User feedback round table open discussion
4:00pm: Close of session